Dexcom Promotes CGM As First-Line Tool In Type 2 Diabetes
Company Combines Education, Advocacy And Clinical Studies To Shift Standard Of Treatment.
Only 14% of people with type 2 diabetes use continuous glucose monitors, although 93% of users report a positive impact on their health. Dexcom is ramping up efforts to close this adoption gap.
